AEGERION PHARMACEUTICALS, INC.

Aegerion Pharmaceuticals, Inc. Share Price

Stocks

AEGR

US00767E1029

Pharmaceuticals

Delayed Nasdaq 02:30:00 30/11/2016 am IST			5-day change	1st Jan Change
1.970 ^USD	+5.35%		+4.23%	-80.50%

10/15/10	AbbVie : Venture capitalists ride biotech wave one drug at a time	RE
15/15/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE

Latest news: Aegerion Pharmaceuticals, Inc.

10/15/10	AbbVie : Venture capitalists ride biotech wave one drug at a time	RE
15/15/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE
06/14/06	Aegerion Pharmaceuticals : AstraZeneca gets sales boost as Nexium drug keeps on giving	RE
19/12/19	SANOFI : FDA panel recommends Sanofi, Isis drug Kynamro for rare disorder	RE

Press Releases: Aegerion Pharmaceuticals, Inc.

29/16/29	Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.	GL
18/16/18	Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan	GL
04/16/04	Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results	GL
24/16/24	Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics	PR
29/16/29	Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	PU

More press releases

News in other languages: Aegerion Pharmaceuticals, Inc.

01/16/01	Aegerion Pharmaceuticals : célèbre la Journée mondiale de la lipodystrophie
01/16/01	Aegerion Pharmaceuticals : weist auf die Bedeutung des World Lipodystrophy Day hin
06/14/06	AstraZeneca : relève encore son objectif de ventes 2014
30/13/30	SANOFI : Un médicament de Sanofi contre une maladie rare approuvé aux USA

Quotes and Performance

1 day

+5.35%

Managers and Directors: Aegerion Pharmaceuticals, Inc.

Manager	Title	Age	Since
Jon Zwinski PSD	President	-	-
Mike Gordon SEC	Corporate Secretary	-	-

Director	Title	Age	Since
Jon Zwinski BRD	Director/Board Member	-	-
Mike Gordon BRD	Director/Board Member	-	-
Diego Ardigo BRD	Director/Board Member	-	-

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	AEGERION PHARMACEUTICALS, INC.	+5.35%	+4.23%	-	-	0
	ELI LILLY AND COMPANY	+1.28%	+2.62%	+51.61%	+100.19%	1,02700Cr
	JOHNSON & JOHNSON	+1.10%	+1.45%	+52.49%	+67.37%	65TCr
	ABBVIE INC.	+0.58%	+3.54%	+19.57%	+73.56%	47TCr
	ROCHE HOLDING AG	+0.46%	+5.49%	+38.85%	+40.76%	35TCr
	NOVARTIS AG	+0.41%	+4.00%	+20.50%	+26.62%	27TCr
	ASTRAZENECA PLC	+0.79%	+6.92%	+11.29%	+16.69%	26TCr
	AMGEN INC.	+0.91%	-0.70%	+38.25%	+45.67%	21TCr
	NOVO NORDISK A/S	+0.67%	+1.77%	-28.32%	-56.74%	19TCr
	GILEAD SCIENCES, INC.	+2.17%	+4.20%	+34.41%	+99.41%	19TCr
	Average	+1.00%	+2.49%	+26.52%	+45.95%	40.02TCr
	Weighted average by Cap.	-0.00%	+2.62%	+35.32%	+62.19%

See all sector performances

Company Profile

Employees

-

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
AEGR Stock

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!